Literature DB >> 11385776

Carcinoma of the corpus uteri.

W T Creasman1, F Odicino, P Maisonneuve, U Beller, J L Benedet, A P Heintz, H Y Ngan, M Sideri, S Pecorelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11385776

Source DB:  PubMed          Journal:  J Epidemiol Biostat        ISSN： 1359-5229


× No keyword cloud information.
  37 in total

1.  Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.

Authors:  Sanjeev Kumar; Karl C Podratz; Jamie N Bakkum-Gamez; Sean C Dowdy; Amy L Weaver; Michaela E McGree; William A Cliby; Gary L Keeney; Gillian Thomas; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2013-10-09       Impact factor: 5.482

2.  Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancy.

Authors:  A Mariani; S S Cha; E J Bergstralh; L A Boardman; S C Dowdy; G L Keeney; K C Podratz; L J Melton
Journal:  Eur J Gynaecol Oncol       Date:  2010       Impact factor: 0.196

3.  Protein profiling of genomic instability in endometrial cancer.

Authors:  Timo Gemoll; Jens K Habermann; Johanna Lahmann; Silke Szymczak; Caroline Lundgren; Nana K Bündgen; Thomas Jungbluth; Britta Nordström; Susanne Becker; Marta I Lomnytska; Hans-Peter Bruch; Andreas Ziegler; Ulf Hellman; Gert Auer; Uwe J Roblick; Hans Jörnvall
Journal:  Cell Mol Life Sci       Date:  2011-07-08       Impact factor: 9.261

4.  Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.

Authors:  Omar Habeeb; Lee Goodglick; Robert A Soslow; Rajiv G Rao; Lynn K Gordon; Osvaldo Schirripa; Steve Horvath; Jonathan Braun; David B Seligson; Madhuri Wadehra
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

5.  Which is worse: uterine papillary serous carcinomas or carcinosarcomas?

Authors:  Taejong Song; Chel Hun Choi; Yoo-Young Lee; Tae-Joong Kim; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

6.  Does duration of hysteroscopy increase the risk of disease recurrence in patients with endometrial cancer? A multi-centre trial.

Authors:  Clemens Tempfer; Georg Froese; Bernd Buerkle; Stephan Polterauer; Christoph Grimm; Nicole Concin; Gerda Hofstetter; Monika Weigert; Martin K Oehler
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

Review 7.  The role of para-aortic lymphadenectomy in endometrial cancer.

Authors:  Mariam M AlHilli; Andrea Mariani
Journal:  Int J Clin Oncol       Date:  2013-02-15       Impact factor: 3.402

8.  The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial.

Authors:  V Seebacher; S Polterauer; C Grimm; H Husslein; H Leipold; K Hefler-Frischmuth; C Tempfer; A Reinthaller; L Hefler
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

9.  The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.

Authors:  Erin C Ward; Anna V Hoekstra; Leen J Blok; P Hanifi-Moghaddam; John R Lurain; Diljeet K Singh; Barbara M Buttin; Julian C Schink; J Julie Kim
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

10.  In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.

Authors:  K El-Sahwi; S Bellone; E Cocco; M Cargnelutti; F Casagrande; M Bellone; M Abu-Khalaf; N Buza; F A Tavassoli; P Hui; D-A Silasi; M Azodi; P E Schwartz; T J Rutherford; S Pecorelli; A D Santin
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.